N = 41 | % | |
---|---|---|
Sex | ||
Female | 27 | 65.8% |
Male | 14 | 34.2% |
Age (years) | ||
Median | 51 (range: 18–82) | |
Groups stratified by tumor and histology | ||
Gynecologic | 15 | 36.5% |
-Uterine endometrioid adenocarcinoma | (4) | |
-Uterine carcinosarcoma | (2) | |
-Cervical adenocarcinoma | (4) | |
-Cervical squamous cell | (4) | |
-Ovarian adenocarcinoma | (1) | |
Colorectal | 12 | 29.5% |
-Rectal adenocarcinoma | (8) | |
-Colon adenocarcinoma | (3) | |
-Anal squamous cell carcinoma | (1) | |
Retroperitoneal sarcoma | 11 | 26.8% |
-Undifferentiated pleomorphic sarcoma | (6) | |
-Liposarcoma | (4) | |
-Fibrosarcoma | (1) | |
Pelvic soft tissue sarcoma | 1 | 2.4% |
-Liposarcoma myxoid | (1) | |
Ewing sarcoma | 1 | 2.4% |
-Ewing sarcoma | (1) | |
Pancreas | 1 | 2.4% |
-Adenocarcinoma | (1) | |
Tumor histology | ||
Epithelial | 26 | 63.4% |
Sarcoma | 15 | 36.6% |